Studying the expression of MEG3 in MM, Benetatos et al. observed hypermethylation of the differentially methylated region (DMR) of the MEG3 promoter in about 60% of patients, which correlated with both disease stage and subtype [38]. Here, MEG3 is linked to Miyoshi myopathy.